Hypothesis: Potassium sparing by angiotensin and aldosterone inhibitors preserves skeletal muscle mass in chronic heart failure
Abstract Background Cachexia complicates many chronic diseases. In chronic or congestive heart failure (CHF), cachexia independently contributes to decreased survival. Although diuretics have long been part of standard treatment of CHF, the addition of angiotensin and aldosterone antagonists to the...
Saved in:
Main Authors: | Lara Zwakman‐Hessels (Author), Miriam Zeillemaker‐Hoekstra (Author), Maarten W. Nijsten (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Renin-Angiotensin Aldosterone System
Published: (2021) -
New Approaches to Blockade of the Renin-Angiotensin-Aldosterone System: Overview of Regulation of the Renin-Angiotensin-Aldosterone System
by: Akira Nishiyama, et al.
Published: (2010) -
Role of renin-angiotensin-aldosterone system inhibitors in heart failure and chronic kidney disease
by: Namrata Singhania, et al.
Published: (2020) -
The renin angiotensin aldosterone system and COVID-19
by: Hadeel A. Alsufyani, et al.
Published: (2020) -
The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma
by: Kazuyuki Hirooka, et al.
Published: (2022)